PharmAust (ASX:PAA) Share Price and News - StockTrack

Market Cap (17-Dec) $111,926,056 (1,449th)	Close (30-Jun) $0.075 0 (0%)	Volume (30-Jun) 0	Shortsold (11-Oct) 108,089 (0.02%) (492nd)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.02

	Subject
	PAA PAA Ann: AGM Presentation
	1 (current) 2 3
	PAA PAA Ann: MPL Manufacturing and Human Trials Update
	PAA PAA Ann: Following Extension of Survival, PAA Prepares Phase 3 Trial
	PAA PAA Ann: Proposed issue of securities - PAA
	PAA PAA Ann: Prospectus
	PAA PAA Ann: Entitlement Options Offer
	PAA PAA Ann: Notice of Annual General Meeting/Proxy Form
	PAA PAA Ann: Letter to shareholders re AGM
	PAA PAA Ann: Broker Briefing Presentation Tech & Biotech Investor Webinar
	PAA PAA Ann: Broker Briefing Investor Webinar
	PAA PAA Ann: Epichem Completes Final Loan Repayment
	PAA PAA Ann: Change of Director's Interest Notice
	PAA PAA Ann: Application for quotation of securities - PAA
	PAA PAA Ann: Appendix 4G & Corporate Governance Statement
	PAA PAA Ann: Appendix 4E & Full Year Statutory Accounts
	PAA PAA Ann: Epichem Completes Build of OHD Benchtop Flow Reactor
	PAA PAA Ann: Virtual Investor Briefing
	PAA PAA Ann: Appendix 4C and Quarterly Update
	PAA PAA Ann: Monepantel and monepantel sulfone COVID-19 anti-viral update
	PAA PAA Ann: PharmAust files patent for monepantel in viral diseases
	PAA PAA Ann: PharmAust and WEHI to Investigate HTLV-1 Viral Infections
	PAA PAA Ann: Science Week Conference Presentation
	PAA PAA Ann: PharmAust establishes monepantel GMP tablet stability
	PAA PAA Ann: Phase IIb Dog Trial Achieves Interim Clinical Endpoints
	PAA PAA Ann: PharmAust receives ethics approval for Phase I trial in MND
	PAA PAA Ann: Dr Kim Agnew appointed Principal Investigator of dog trial
	PAA PAA Ann: Appendix 4C and Quarterly Update
	PAA PAA Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL
	PAA PAA Ann: Epichem OHD Presentation - Waste to Fuels Technology
	PAA PAA Ann: PharmAust Receives $750k R&D Tax Incentive Refund
	PAA PAA Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
	PAA PAA Ann: Trading Halt
	PAA PAA Ann: Pause in Trading
	PAA PAA Ann: Update on Phase IIb Clinical Trial of Monepantel in Pet Dogs
	PAA PAA Ann: Epichem business support program for advanced technologies
	PAA PAA Ann: Licensing Agreement to Develop Waste to Fuels Technology
	PAA PAA Ann: Appendix 4D & Half Year Report
	PAA PAA Ann: Update on Phase IIb Clinical Trial recruitment
	PAA PAA Ann: Update on COVID-19 testing in the Netherlands
	PAA PAA Ann: Virtual Investor Briefing
	PAA PAA Ann: Appendix 4C and Quarterly Update
	PAA PAA Ann: Epichem Awarded $200K WasteSorted e-Waste Grant
	PAA PAA Ann: Leiden University Medical Centre Monepantel COVID-19 Testing
	PAA PAA Ann: PAA & ONJCRI to Continue MPL Pre-clinical Investigations
	PAA PAA Ann: Appendix 2A & s708 notice
	PAA PAA Ann: PAA Commences Manufacture of GMP-Grade MPL for Human Trials
	PAA PAA Ann: PharmAust to Commence Phase IIb Dog Cancer Trial
	PAA PAA Ann: Epichem Awarded Contract Extension from DNDi
	PAA PAA Ann: Appendix 2A & s708 notice (exercise of options)
	PAA PAA Ann: Results of Annual General Meeting

Similar Companies

Cann Group

CAN

Creso Pharma

CPH

Ecofibre

EOF

Incannex Healthcare

IHL

Medical Developments International

MVP

Mayne Pharma Group

MYX

Neuren Pharmaceuticals

NEU

Probiotec

PBP

Recce Pharmaceuticals Ltd

RCE

Starpharma Holdings

SPL

End of Day Prices

Date	Close	Volume	Change
16-Dec	$0.17	882,169	-0.02 (8.33%)
13-Dec	$0.18	127,632	-0.01 (2.70%)
12-Dec	$0.19	382,091	+0.01 (5.71%)
11-Dec	$0.18	620,427	0.00 (0.00%)
09-Dec	$0.18	105,356	+0.00 (2.94%)
06-Dec	$0.17	261,837	+0.01 (6.25%)
05-Dec	$0.16	889,407	-0.02 (11.11%)
03-Dec	$0.18	65,135	+0.01 (2.86%)
02-Dec	$0.18	490,456	-0.01 (5.41%)
29-Nov	$0.19	163,628	+0.01 (5.71%)
28-Nov	$0.18	217,540	0.00 (0.00%)
27-Nov	$0.18	1,424,745	-0.01 (5.41%)
26-Nov	$0.19	414,413	-0.01 (2.63%)
25-Nov	$0.19	308,103	0.00 (0.00%)
22-Nov	$0.19	750,714	0.00 (0.00%)
5 up, 6 down, and 4 flat days

High -	Low -	Trades -	Turnover $0	Volume 0
5 June 2026 at 4:29am

High -	Low -	Trades -	Turnover $0	Volume 0
5 June 2026 at 4:29am

PharmAust Health Care

$0.075 (0%)

$0.075 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices